Thiazolidinediones inhibit the expression of β3-adrenergic receptors at a transcriptional level

Diabetes

Volumn 49, Issue 12, 2000, Pages 2108-2115

  Bakopanos, Evangelos ^a   Silva, J Enrique ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADENYLATE CYCLASE; DARGLITAZONE; LUCIFERASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RNA PRECURSOR; TROGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HALF LIFE TIME; LIPOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE;

EID: 0033656675     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.12.2108     Document Type: Article

References (51)

1. 3-adrenergic receptor
2. Molecular cloning and expression of the rat beta 3-adrenergic receptor
3. An adipose tissue-specific β-adrenergic receptor: Molecular cloning and down-regulation in obesity
4. Molecular characterization of the mouse β3-adrenergic receptor: Relationship with the atypical receptor of adipocytes
5. Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs
6. 3-agonist, on energy balance and brown and white adipose tissues in rats
7. Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats
8. 3-adrenoceptor agonists in the treatment of obesity and diabetes
9. Distribution of beta 3-adrenoceptor mRNA in human tissues
10. Tissue distribution of β3-adrenergic receptor mRNA in man
11. Expression of the beta 3-adrenergic receptor in human white adipose tissue
12. New therapeutic agents for the treatment of insulin resistance and NIDDM
13. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activator receptor gamma (PPAR gamma)
14. Peroxisome proliferator-activated receptor (PPAR) gamma: Adipose-predominant expression and induction early in adipocyte differentiation
15. Stimulation of adipogenesis in fibroblasts by PPAR ganuna 2, a lipid-activated transcription factor
16. mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer
17. Role of melacortinergic neurons in feeding and the agouti obesity syndrome
18. Induction of uncoupling protein in brown adipose tissue: Synergy between norepinephrine and pioglitazone, and insulin-sensitizing agent
19. Activation of the nuclear receptor peroxisome proliferator-activated gamma promotes brown adipocyte differentiation
20. cAMP response sequences of the uncoupling protein gene are sequentially recruited during darglitazone-induced brown adipocyte differentiation
21. Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissues and skeletal muscle
22. Increased adipose expression of the uncoupling protein- 3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes
23. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
24. The promoter and intron/exon structure of the human and mouse beta 3-adrenergic-receptor genes
25. PPAR-γ gene expression is elevated in skeletal muscle of obese and type II diabetic subjects
26. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans: No alteration in adipose tissue of obese and NIDDM patients
27. Alphaamanitin: A specific inhibitor of one of two DNA-pendent RNA polymerase activities from calf thymus
28. Specific inhibition of nuclear RNA polymerase II by alpha-amanitin
29. Quantitative RT-PCR on CYP1A1 heterogeneous nuclear RNA: A surrogate for the in vitro transcription run-on assay
30. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha
31. Transcriptional acitvation by PPARgamma is inhibited by phosphorylation at a consensus MAP kinase site
32. Coexisting beta 1- and atypical beta-adrenergic receptors cause redundant increases in cyclic AMP in human neuroblastoma cells
33. 3-adrenoceptor expression in 3T3-T 442A differentiating adipocytes
34. 3-adrenergic receptor gene expression and mRNA splice variants in adipocytes
35. 3adrenergic receptors in brown and white adipose tissue
36. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR-gamma
37. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation
38. Mechanisms of insulin resistance and new pharmacological approaches to metabolism and diabetic complications
39. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L 1 adipocytes
40. Ligand-independent activation domain in the N terminus of the peroxisome proliferator-activated receptor γ (PPARγ): Differential activity of PPARγ1 and - 2 isoforms and influence of insulin
41. Thyroid hormone-independent interaction between the thyroid hormone receptor beta 2 amino terminus and coactivators
42. A unique role of the beta-2 thyroid hormone receptor isoform in negative regulation by thyroid hormone: Mapping of a novel amino-terminal domain important for ligand-independent activation
43. 3 receptors: A promising antidiabetic and antiobesity agent
44. Alpha- and betaadrenergic induction of the expression of the uncoupling protein thermogenin in brown adipocytes differentiated in culture
45. 3-adrenergic receptor responsiveness in 3T3-F442A adipocytes: Evidence for a transcriptional mechanism
46. 3-adrenergic receptor expression in 3T3-F442A adipocytes: A mechanism for repressing the cAMP signaling pathway
47. Induction of uncoupling protein- 2 mRNA by troglitazone in the pancreatic islets of Zucker diabetic fatty rats
48. Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: Regulation byperoxisome proliferator-activated receptor gamma
49. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma
50. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice
51. Effect of troglitazone on leptin production: Studies in vitro and in human subjects